Long-term, Randomized Safety Study of MP29-02 (a Novel Intranasal Formulation of Azelastine Hydrochloride and Fluticasone Propionate in an Advanced Delivery System) in Subjects With Chronic Rhinitis-Reference-Cited by-同舟云学术

Long-term, Randomized Safety Study of MP29-02 (a Novel Intranasal Formulation of Azelastine Hydrochloride and Fluticasone Propionate in an Advanced Delivery System) in Subjects With Chronic Rhinitis

Published:2014-03 Issue:2 Volume:2 Page:179-185
ISSN:2213-2198
Container-title:The Journal of Allergy and Clinical Immunology: In Practice
language:en
Short-container-title:The Journal of Allergy and Clinical Immunology: In Practice

Author:

Berger William E.,Shah Shailen,Lieberman Phil,Hadley James,Price David,Munzel Ullrich,Bhatia Sanjay

Publisher

Elsevier BV

Subject

Immunology and Allergy

Reference15 articles.

1. Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device;Hampel;Ann Allergy Asthma Immunol,2010

2. Clinically relevant effect of a new intranasal therapy (MP29-02) in allergic rhinitis assessed by responder analysis;Meltzer;Int Arch Allergy Immunol,2013

3. A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis;Carr;J Allergy Clin Immunol,2012

4. MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial of efficacy and safety;Meltzer;Allergy Asthma Proc,2012

5. International Committee on Harmonization Harmonized Tripartite Guidelines on Good Clinical Practice (1996). Available from: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E6_R1/Step4/E6_R1__Guideline.pdf. Accessed June 17, 2011.

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Use of Azelastine Hydrochloride/Fluticasone Propionate in the Management of Allergic Rhinitis in Asia: A Review;Journal of Asthma and Allergy;2024-07

2. Nonallergic Rhinopathy: A Comprehensive Review of Classification, Diagnosis, and Treatment;The Journal of Allergy and Clinical Immunology: In Practice;2024-06

3. An Observational Study to Determine the Real-Life Effectiveness of MP-AzeFlu® in Austrian Patients with Persistent Allergic Rhinitis;Drugs - Real World Outcomes;2024-02-13

4. A Clinical Study to Assess the Efficacy and Safety of MP-AzeFlu Nasal Spray in Comparison to Commercially Available Azelastine Hydrochloride and Fluticasone Propionate Nasal Sprays in Chinese Volunteers with Allergic Rhinitis;Pulmonary Therapy;2023-08-14

5. The Comparative Bioavailability of Fluticasone and Azelastine Delivered as a Single Fixed Dose Combination (MP-AzeFlu) in Comparison to Two Different Formulations of Azelastine and Fluticasone Propionate Following Intranasal Administration in Healthy Chinese Volunteers;Journal of Asthma and Allergy;2023-06